TuesdayApr 02, 2019 11:55 am

QualityStocksNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Partners with HelloMD to Deliver More Value-Added Services

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) today announced its entry into a delivery fulfillment agreement with HelloMD, the country’s leading digital healthcare platform for cannabis doctors, consumers and brands. According to the update, Wildflower’s partnership with HelloMD’s e-commerce solution intends to expand on its license to deliver more value-added services to the L.A. community. “HelloMD has been a significant wholesale customer and provides us with a great position as a premium health and wellness brand,” Wildflower Brands CEO William MacLean said in the news release. “I am very happy to see our relationship grow to further bring quality information and…

Continue Reading

TuesdayApr 02, 2019 11:45 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Appoints Chief Financial Officer Jon Paul, Craig Heimark Takes Role of Chief Strategy Officer

Leading California edibles manufacturer Plus Products (CSE: PLUS) (OTCQB: PLPRF) this morning announced that it has appointed veteran senior corporate finance executive and certified public accountant Jon Paul as its chief financial officer reporting to PLUS co-founder and CEO Jake Heimark. The company further announced that, effective immediately, Craig Heimark has resigned as the chief financial officer and has been appointed as the chief strategy officer, and will remain as chairman, secretary and a director. “Jon has more than 30 years of experience in senior financial management, including roles as CFO and senior financial consultant at both private and public…

Continue Reading

TuesdayApr 02, 2019 11:35 am

ChineseInvestors.com Inc. (CIIX) Subsidiary Launches High-End, Full-Spectrum Luxury Brand CBD Oil

The new CBD oil product was introduced at the Financial Carnival Event in San Francisco The full-spectrum oil joins CIIX’s other CBD products, including OptHemp and the OPT2Mist CBD-infused sprays CEO sees possibility of reaching $6-$10 million in annual sales volume, facilitating uplisting to the New York Stock Exchange or the Nasdaq Capital Market ChineseInvestors.com Inc. (OTCQB: CIIX) has added a high-end, full-spectrum brand of CBD oil to its CBD offerings through subsidiary ChineseHempOil.com Inc. The new product line is available at www.365CWC.com. CIIX said in a news release that the new, branded oil should have a positive impact on…

Continue Reading

TuesdayApr 02, 2019 11:09 am

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Set to Thrive within Blossoming Cosmeceutical Industry

Therma Bright Inc.’s proprietary technology has received Class II medical device status from the U.S. Food and Drug Administration The global market for cosmeceuticals was valued at nearly $47 billion in 2017 and is estimated to see continued growth The company is waiting on regulatory approvals for its thermal therapy technology, which incorporates the use of cannabis or cannabidiol Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF), a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical (the convergence of cosmetic and pharmaceutical products) industry, offers relief for insect and marine life bites and stings, which is…

Continue Reading

TuesdayApr 02, 2019 10:57 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Elects Globally Recognized Corporate and Political Strategist as Board Chairman

Royalty company for the U.S. licensed medical cannabis industry FinCanna Capital (CSE: CALI) (OTCQB: FNNZF) today announced its election of Morris L. Reid to the position of chairman of the board. Reid, a partner at leading high-stakes public strategy firm, Mercury, has served as a director of FinCanna for the past two years and is based in Washington, D.C. and London. For over 15 years, Morris has worked with high-profile individuals, corporate executives and government officials, advising on high-level political and corporate issues. “We are honored to have a man of Morris’s stature and experience take on the important role…

Continue Reading

TuesdayApr 02, 2019 10:33 am

Marijuana Company of America Inc. (MCOA) Officially Launches hempSMART in UK, Acquires Interest in California Company

Most of MCOA’s projects involve the cultivation and distribution of hemp-derived products The company has officially launched its industrial hemp-based, CBD-formulated hempSMART products in the United Kingdom MCOA recently entered into an LOI with Natural Plant Extracts of California An umbrella company, Marijuana Company of America Inc. (OTCQB: MCOA) supports an array of portfolio businesses that participate in the cannabis industry. Primarily an industrial hemp business, MCOA’s hempSMART company is focused on producing premier-quality botanical supplements derived from organically grown industrial hemp and synergistic botanicals (http://ibn.fm/jL0vQ). MCOA is headquartered in Escondido, California. Fundamentally, hempSMART offers a line of industrial hemp-derived cannabidiol…

Continue Reading

TuesdayApr 02, 2019 10:03 am

QualityStocksNewsBreaks – Sharing Services Global Corporation’s (SHRV) Elepreneur Subsidiary Founder Featured in ‘Networking Times’

Diversified holding company Sharing Services Global Corporation (OTCQB: SHRV) on Monday announced that Robert Oblon, founder of the company’s wholly owned subsidiary, Elepreneur LLC, is featured in the Spring 2019 issue of Networking Times. Published by Gabriel Media Group, Inc., the direct selling industry publication’s exclusive edition titled “Elevating Health, Wealth and Happiness” showcases Oblon and includes a 15-page cover story that highlights his background spanning over 22 years in the online travel industry and his passion for creating direct selling and network marketing models. Also covered is the unique story of the birth of the company Elepreneur, as well…

Continue Reading

TuesdayApr 02, 2019 9:53 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Posts Clinical, Corporate and Financial Update

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) on Monday provided a clinical, corporate and financial update for the year ended December 31, 2018. Among other highlights, Genprex reached various milestones in 2018 and early 2019 which included completing its initial public offering (“IPO”) and listing of common stock on NASDAQ Capital Market, completing a $10 million private placement, and securing a contract with Accenture to provide clinical data management services to help fast-track the clinical development of Oncoprex(TM). “Over the past year, we made great progress in advancing the development of our gene therapy platform, including Oncoprex(TM) immunogene therapy for…

Continue Reading

MondayApr 01, 2019 1:23 pm

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Readies Online Sales Strategy for New InterceptCS Cold Sore Prevention Device

THRBF offers an IoT- and Bluetooth-enabled device for cold-sore prevention Its sales strategy is part of the company’s larger focus on developing products for the dermatology market THRBF’s proprietary technology is designed to prevent cold sores in the OTC sector, which is projected to record significant sales growth Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is offering a new generation of technology in the burgeoning skin care market. The company is specifically planning to target sales growth for its high gross-margin InterceptCS* cold sore prevention device with a new website, social media campaign and online sales strategy (http://ibn.fm/qqEgF). THRBF’s new InterceptCS…

Continue Reading

MondayApr 01, 2019 12:55 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Launches Its Largest Cannabinoid Research Program

The R&D program will focus on the proprietary Lexaria DehydraTECH delivery technology with the purpose of enhancing it further Results could contribute to new patent filings in the future; in addition, the program will examine more extensively the way DehydraTECH-enabled CBD outperforms generic CBD Lexaria-designed nanotech enhancements will also be included in the program Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is launching its largest cannabinoid research and development program to date. The program consists of 11 separate animal studies, according to a company press release (http://ibn.fm/xidEM). The Lexaria in vitro study design was…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered